Skip to content

Serological response to COVID-19 and association with MR containing vaccine

Assessment of serological response to COVID-19 and its association with exposure to MR-containing vaccine: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030363
Enrollment
60
Registered
2021-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group 1: COVID-19 positive children who have received MR-containing vaccine atleast 6 weeks before date of enrolment Group 2: COVID 19 positive children who have not received MR containing vaccine

Exclusion criteria

Exclusion criteria: Children with past infection due to measles or rubella, immunodeficiency states (both primary and secondary), chronic diseases (congenital heart disease, respiratory diseases that cause pulmonary function impairment, hypothyroidism, IDDM), history of blood transfusion within last 3 months, severe malnutrition (wt-for-ht

Design outcomes

Primary

MeasureTime frame
Comparison of COVID-19 antibody titres between vaccinated and unvaccinated childrenTimepoint: At 2, 6 and 12 weeks from date of positive test

Secondary

MeasureTime frame
Comparison of disease severity between vaccinated and unvaccinated subjects. Comparison of antibody titres between children who have received 1 dose of MR-containing vaccine with those who have received 2 doses of the same.Timepoint: At 2, 6 and 12 weeks from date of positive test

Countries

India

Contacts

Public ContactDr Jahnavi Shrivastava

University College of medical sciences & Guru Tegh Bahadur Hospital

manish_2710@yahoo.com9811036569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026